Skip to main content

Establishment Labs Holdings Inc 10-Q for FY2026 Q3

Establishment Labs Holdings Inc. (ESTA)

10-Q 2026-11-06 For: 2026-09-30
View Original
Added on November 07, 2026

About this 10-Q

Establishment Labs Holdings Inc filed this 10-Q on November 6, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

ESTABLISHMENT LABS HOLDINGS INC. reported nine-month revenue of $199.4 million, up 36.2%, while net losses narrowed to $35.8 million from $48.4 million. Cash was $75.8 million as of September 30, 2026, and FDA approved additional smaller Motiva implant sizes. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$71.99M
up 33.9% from $53.78M a year earlier
Net loss
$10.71M
compared with a net loss of $11.15M a year earlier
Diluted EPS
-$0.35
compared with -$0.38 a year earlier